Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

5.0%

46 terminated/withdrawn out of 913 trials

Success Rate

89.4%

+2.9% vs industry average

Late-Stage Pipeline

12%

105 trials in Phase 3/4

Results Transparency

2 of 389 completed trials have results

Key Signals

112 recruiting2 with results42 terminated4 withdrawn

Enrollment Performance

Analytics

N/A

416(68.8%)

Phase 4

58(9.6%)

Phase 2

58(9.6%)

Phase 3

47(7.8%)

Phase 1

26(4.3%)

605Total

N/A(416)

Phase 4(58)

Phase 2(58)

Phase 3(47)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (913)

Showing 20 of 913 trials

NCT01272167Not ApplicableCompleted

Effects of a Long-term Grapefruit Juice Consumption on Vascular Protection and Bone Metabolism

Role: lead

NCT05163171Completed

Prevalence of the Victimization and the Perpetration of Intimate Partner Violence Among the Patients From Puy-de-Dôme and Paris Consulting or Being Hospitalized for Addiction Problems and Their Expectations From General Practitioners (VIA-MG)

Role: lead

NCT02046083Phase 2Completed

Peanut Oral Induction Tolerance in Peanut's Allergic Teenagers

Role: lead

NCT07738549Not ApplicableNot Yet Recruiting

Diagnosis of Hidden Hearing Loss in Adults : Refining the Audiological Profile for Better Diagnosis.

Role: lead

NCT07740356Recruiting

Prevalence of Brief Suicidal Crisis in Psychiatric Settings

Role: lead

NCT07471438Not ApplicableRecruiting

Concordance Between Inflammatory Activity Assessed by Enteric MRI With and Without Intestinal Distension Product in Patients With Ileal Crohn's Disease.

Role: lead

NCT07278583Recruiting

Evaluation of Heart Failure Telemonitoring Eligibility Criteria

Role: lead

NCT04973423Not ApplicableRecruiting

STUDY OF THE ADDED VALUE OF A TRANSMURAL EVALUATION IN PATIENTS WITH CROHN'S DISEASE UNDER BIOTHERAPY WITH CLOSE FECAL CALPROTECTIN FOLLOW-UP

Role: lead

NCT06284161Not ApplicableRecruiting

QCT in ALS Diagnosis, Mechanistic Understanding and Follow-up

Role: lead

NCT06594263Completed

Validation of the French Version of the Perinatal Assessment of Paternal Affectivity (PAPA)

Role: lead

NCT05871411Recruiting

Validation of Visual Analog Scales to Measure SatisfactiOn and WELL-being at Work (SoWell-VAS)

Role: lead

NCT07472569Enrolling By Invitation

Trust in Institutions, Environment, and Physical Activity

Role: lead

NCT02907554Phase 4Completed

Cyclosporine A Pretreatment and Kidney Graft Function

Role: lead

NCT07377240Not ApplicableRecruiting

Study of Obstacles and Barriers to Changing Risky Eating Behaviors in Families of Children With Severe Early Childhood Caries (QUALIKIDS).

Role: lead

NCT07727174Not ApplicableNot Yet Recruiting

A Clinical Trial Evaluating the Influence of the Ingredients MyCondro™ and Bovine Chondroitin Sulfate on the Behavior of Cells in the Osteoarticular Sphere

Role: collaborator

NCT07718477Not Yet Recruiting

Compare the Intensity of Pain Felt by Children During the Local Anesthesia Procedure to That Perceived by the Accompanying Parent.

Role: lead

NCT06085040Not ApplicableCompleted

Pedicatric Obesity - Weight - Energy - Loss - Load

Role: lead

NCT07715513Completed

Reducing Fluids Intakes in Neonatal Intensive Care

Role: lead

NCT07706543Not ApplicableNot Yet Recruiting

Evaluation of a French Hospital Discharge Therapeutic Education Program by Nurses for Heart Failure Patient (EduSor)